Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials

Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials

Compartilhe

Publicado por: - Oncologista - CRM 170.446 | RQE 97248
O Dr. Roberto Pestana (CRM 170.446 | RQE 97248) é oncologista clínica do centro de oncologia do Hospital Israelita Albert Einstein. Além disso, ele é médico do ambulatório de sarcomas do Hospital Municipal Vila Santa Catarina.